NewsPronto

 
Men's Weekly

.

PR Newswire

Exopharm Gains US Patent Enabling Commercial Production of Exosome Medicines

  • Written by PR Newswire Asia - News Pronto RSS
  • US Patent and Trademark Office has granted Exopharm patent US 11202805, for its LEAP™ exosome purification technology.
  • LEAP™ enables large-scale, clinical grade commercial production of exosomes needed to underpin the emerging field of exosome medicines.
  • Exopharm is seeking potential partners and licensees, with LEAP™ having the...

Read more: Exopharm Gains US Patent Enabling Commercial Production of Exosome Medicines

More Articles ...

  1. Niftify Announces U.S. Launch and Partnership with Blockchain Platform Polygon
  2. Australia's first laser nuclear fusion company appoints world-leading scientific board; publishes groundbreaking research
  3. Landis+Gyr Divests Stake in Intellihub Joint Venture
  4. The New Era Biotechnology Brings The Cooperation Between China And Belarus To A New Level
  5. 2021 Sustainability Report of Sai Life Sciences highlights the momentum gained in its Sustainability choices